Send to

Choose Destination
Int J Gynaecol Obstet. 1991 Aug;35(4):327-30.

The value of human menopausal gonadotropin treatment in patients with unexplained infertility.

Author information

Hacettepe University, Faculty of Medicine, Department of Obstetrics and Gynecology, Ankara, Turkey.


The role of multiple ovulation with human menopausal gonadotropin (HMG) in the treatment of unexplained infertility is evaluated. Of a total 73 patients with unexplained infertility, 39 received four cycles of HMG, whereas, 34 were left untreated. Eight (20.5%) women conceived during HMG treatment, in comparison to only 1 (2.9%) in the control group (P less than 0.05). This study gives further credit to the value of HMG treatment for unexplained infertility.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center